Publication: Screening for Depression and Anxiety in Patients with Active Uveitis
| dc.contributor.author | AKMAN, MEHMET | |
| dc.contributor.authors | Onal, Sumru; Oray, Merih; Yasa, Cagla; Akman, Mehmet; Uludag, Gunay; Akbay, Aylin Koc; Tugal-Tutkun, Ilknur | |
| dc.date.accessioned | 2022-03-12T22:27:25Z | |
| dc.date.accessioned | 2026-01-11T10:37:35Z | |
| dc.date.available | 2022-03-12T22:27:25Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Purpose: To screen for psychological disorders in patients with active uveitis. Methods: Patients were screened for depression (BDI-II), state anxiety (STAI-I), VR-QOL (NEI-VFQ-25), and HR-QOL (SF-36). Association of depression and anxiety with sociodemographic and clinical parameters and with VR-QOL and HR-QOL were analyzed. Multivariate linear regression models were constructed for NEI-VFQ-25 and SF-36 subscales. Results: Of 99 patients, 37.3% screened positive for depression and 52.5% for anxiety. Depressed patients had lower visual acuity in the better seeing eye (p = 0.013) and more frequently panuveitis (p = 0.018). Anxious patients were younger (p = 0.009), had earlier onset of uveitis (p = 0.015), and had more frequently panuveitis (p = 0.016). Bivariate comparisons showed significant associations between psychological disorders and VR-QOL and HR-QOL. Significant bivariate associations were mostly lost in multivariate analyses for anxiety, but were preserved for depression. Conclusions: A positive screening test for depression and anxiety is common in patients with uveitis. Low vision and panuveitis are associated with depression. Depression is associated with impairment of VR-QOL and HR-QOL. | |
| dc.identifier.doi | 10.1080/09273948.2017.1319959 | |
| dc.identifier.eissn | 1744-5078 | |
| dc.identifier.issn | 0927-3948 | |
| dc.identifier.pubmed | 28548554 | |
| dc.identifier.uri | https://hdl.handle.net/11424/235200 | |
| dc.identifier.wos | WOS:000452433400015 | |
| dc.language.iso | eng | |
| dc.publisher | TAYLOR & FRANCIS INC | |
| dc.relation.ispartof | OCULAR IMMUNOLOGY AND INFLAMMATION | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Anxiety | |
| dc.subject | BDI-II | |
| dc.subject | depression | |
| dc.subject | general health | |
| dc.subject | NEI-VFQ-25 | |
| dc.subject | quality of life | |
| dc.subject | SF-36 | |
| dc.subject | STAI-I | |
| dc.subject | uveitis | |
| dc.subject | vision | |
| dc.subject | QUALITY-OF-LIFE | |
| dc.subject | ANTERIOR UVEITIS | |
| dc.subject | VISUAL-ACUITY | |
| dc.subject | STANDARDIZATION | |
| dc.subject | COMORBIDITY | |
| dc.subject | PREVALENCE | |
| dc.subject | DISORDERS | |
| dc.subject | IMPACT | |
| dc.subject | MOOD | |
| dc.title | Screening for Depression and Anxiety in Patients with Active Uveitis | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 1093 | |
| oaire.citation.issue | 7 | |
| oaire.citation.startPage | 1078 | |
| oaire.citation.title | OCULAR IMMUNOLOGY AND INFLAMMATION | |
| oaire.citation.volume | 26 |
